PTG
  • Home
  • Research
    • PTG Research
    • iBox technology
    • Publications
    • Collaborations
    • Granted Projects
    • Awards
    • Database access
  • Platforms
    • Technical & Analytical Platforms
  • Team
    • Current team
    • PTG alumni
  • News & Media
    • Latest news
    • Photo and Video Gallery
    • PTG in the media
  • Job offers
  • About

Our abstracts at the American Transplant Congress (ATC) 2016

6/11/2016

 
Picture
2016 American Transplant Congress (ATC)
June 11-15, 2016 in Boston, MA
Sunday June 12, 2016


1/ Complement-Binding Donor-Specific Anti-HLA Antibodies Are Associated with Severe Kidney Allograft Arteriosclerosis


Concurrent Session: Novel Markers of Long Term Kidney Transplant Outcomes (2:30 PM-4:00 PM)
Ballroom A - 2:30 pm
A. Loupy, D. Viglietti, J. Duong Van Huyen, D. Glotz, C. Legendre, A. Zeevi, C. Lefaucheur. Necker Hospital, Paris, France; Saint-Louis Hospital, Paris, France; University of Pittsburgh Medical Center, Pittsburgh
The role of circulating donor-specific anti-HLA antibodies (DSA) in the development of accelerated arteriosclerosis have been recently reported in kidney transplant recipients. This study investigated the characteristics of DSA that are associated with the severity of allograft arteriosclerosis.
We enrolled 744 consecutive kidney transplantation performed between January 1, 2004 and January 1, 2010 at Necker Hospital (Paris, France), with systematic assessment of injury phenotype and arteriosclerotic lesions using the vascular fibrous intimal thickening (cv) Banff score on allograft biopsies performed at one year after transplantation. We assessed circulating DSA and their characteristics (specificity, HLA class, mean fluorescence intensity [MFI] and C1q-binding) at six months after transplantation.
We identified 281 patients with cv0 score, 213 patients with cv1 score, 189 patients with cv2 score and 61 patients with cv3 score. The distribution of DSA according to cv score was the following: 47/281 (17%) in cv0 patients, 39/213 (18%) in cv1 patients, 63/189 (33%) in cv2 patients and 28/61 (46%) in cv3 patients. Immunodominant DSA (iDSA) MFI level was positively correlated with the severity of arteriosclerosis (Spearman's rho=0.23, p=0.002), with a mean MFI of 3204.0±3725.2 in cv0 patients, 3760±3598 in cv1 patients, 4892±4676 in cv2 patients and 5541±3892 in cv3 patients. C1q-binding DSA prevalence increased with the severity of allograft arteriosclerosis: 8/281 (3%) in cv0 patients, 6/213 (3%) in cv1 patients, 25/189 (13%) in cv2 patients and 9/61 (15%) in cv3 patients (p<0.001). Patients with C1q-binding iDSA had a higher cv score compared with patients with non-C1q-binding DSA (1.7±1.0 versus 1.3±1.1, respectively, p=0.01). The C1q-binding capacity of DSA was associated with increased microvascular inflammation (p<0.001) and C4d deposition in peritubular capillaries or arteries (p<0.001).
This study shows a biological gradient between DSA MFI level and the severity of allograft arteriosclerosis. The complement-binding capacity of DSA is associated with an increased severity of arteriosclerosis and complement deposition in allograft.

Read More

    Paris Transplant Group

    Our global aim is to accelerate the translation of immunological and gene expression discoveries into the clinical field by filling the gap between basic science and applied biomedical researches.

    CATEGORIES

    Awards
    Events
    Job offers
    Press Releases
    Publications

    See also

    Press coverage
    Video and ​Picture gallery

    ALl

    All
    Alexandre Loupy
    Antoine Bouquegneau
    Antoine Durrbach
    Antoine Roux
    Awards
    Blaise Robin
    Carmen Lefaucheur
    Charlotte Debiais
    Charlotte Loheac
    Christophe Legendre
    Daniel Yoo
    Dany Anglicheau
    Denis Glotz
    Denis Viglietti
    Dina Zielinski
    Elodie Bailly
    Events
    Gillian Divard
    Guillaume Bonnet
    Guillaume Coutance
    Huanxi Zhang
    Jean Luc Taupin
    Jean Paul Duong Van Huyen
    Jean Philippe Empana
    Jessy Dagobert
    Job
    Juliette Gueguen
    Kevin Louis
    Marc Raynaud
    Marie-Cécile Bories
    Marion Rabant
    Maud Racape
    Michel Delahousse
    Olivier Aubert
    Pascal Leprince
    Patrick Bruneval
    Peter Reese
    Press Releases
    Publications
    Shaida Varnous
    Valentin Goutaudier
    Xavier Jouven
    Yassine Bouatou
    Zeynep Demir

    Archives

    October 2021
    September 2021
    August 2021
    July 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    May 2020
    March 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    March 2019
    February 2019
    December 2018
    September 2018
    May 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    June 2016
    April 2016
    October 2015
    June 2015
    August 2014
    January 2014
    September 2013
    January 2013
    June 2011
    August 2010
    May 2009

    RSS Feed

Paris Transplant Group

About PTG
PTG Team
​​Careers at PTG
​Latest News
​
Awards
Video and Picture Gallery

PTG in the Press
​Contact us

Research

iBox technology
PTG Research
PTG Publications
Covid-related research 🔓

Platforms

Technical platforms

Partnerships

Research collaborations
​Database access
​

Search

LEGAL NOTICE AND PRIVACY POLICY
© COPYRIGHT 2022. ALL RIGHTS RESERVED.

 LABS EXPLORER for the PARIS TRANSPLANT GROUP.
  • Home
  • Research
    • PTG Research
    • iBox technology
    • Publications
    • Collaborations
    • Granted Projects
    • Awards
    • Database access
  • Platforms
    • Technical & Analytical Platforms
  • Team
    • Current team
    • PTG alumni
  • News & Media
    • Latest news
    • Photo and Video Gallery
    • PTG in the media
  • Job offers
  • About